For: | Muc-Wierzgoń M, Nowakowska-Zajdel E, Dzięgielewska-Gęsiak S, Kokot T, Klakla K, Fatyga E, Grochowska-Niedworok E, Waniczek D, Wierzgoń J. Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer. World J Gastroenterol 2014; 20(29): 9759-9774 [PMID: PMC4123364 DOI: 10.3748/wjg.v20.i29.9759] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i29/9759.htm |
Number | Citing Articles |
1 |
Drew Magowan, Mansour Abdulshafea, Dominic Thompson, Shri-Ishvarya Rajamoorthy, Rhiannon Owen, Dean Harris, Susan Prosser. Blood-based biomarkers and novel technologies for the diagnosis of colorectal cancer and adenomas: a narrative review. Biomarkers in Medicine 2024; 18(9): 495 doi: 10.1080/17520363.2024.2345583
|
2 |
Dariusz Waniczek, Zbigniew Lorenc, Mirosław Śnietura, Mariusz Wesecki, Agnieszka Kopec, Małgorzata Muc-Wierzgoń. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer. Archivum Immunologiae et Therapiae Experimentalis 2017; 65(5): 445 doi: 10.1007/s00005-017-0463-9
|
3 |
Tianhao Zhang, Kaitao Yuan, Yingzhao Wang, Mingze Xu, Shirong Cai, Chuangqi Chen, Jinping Ma. Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.652354
|
4 |
|
5 |
Yerim Cho, Su Bee Park, Jin Young Yoon, Min Seob Kwak, Jae Myung Cha. Neutrophil to lymphocyte ratio can predict overall survival in patients with stage II to III colorectal cancer. Medicine 2023; 102(11): e33279 doi: 10.1097/MD.0000000000033279
|
6 |
Stephan Neumann, Julia Schuettler, Meike Frenz, Franz-Josef Kaup, Frank Gessler. Investigation of serum Ki-67 as a biomarker in tumor-bearing dogs. Research in Veterinary Science 2017; 110: 16 doi: 10.1016/j.rvsc.2016.10.012
|
7 |
Tomi Akinyemiju, Justin Xavier Moore, Suzanne E. Judd, Maria Pisu, Michael Goodman, Virginia J. Howard, Leann Long, Monika Safford, Susan C. Gilchrist, Mary Cushman. Pre-diagnostic biomarkers of metabolic dysregulation and cancer mortality. Oncotarget 2018; 9(22): 16099 doi: 10.18632/oncotarget.24559
|
8 |
Aldona Kasprzak. Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer. International Journal of Molecular Sciences 2021; 22(12): 6434 doi: 10.3390/ijms22126434
|
9 |
Claudiu Răchieriu, Dan Tudor Eniu, Emil Moiş, Florin Graur, Carmen Socaciu, Mihai Adrian Socaciu, Nadim Al Hajjar. Lipidomic Signatures for Colorectal Cancer Diagnosis and Progression Using UPLC-QTOF-ESI+MS. Biomolecules 2021; 11(3): 417 doi: 10.3390/biom11030417
|
10 |
Rania Naguib, Mohamed Abouegylah, Sherif Sharkawy, Amel A Fayed, Hend Naguib. Evaluation of Serum Levels of Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Patients With Colorectal Cancer: A Case-Control Study. Cureus 2021; doi: 10.7759/cureus.19881
|
11 |
Sujha Subramanian, Georgiy Bobashev, Robert J. Morris, Sonja Hoover. Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?. Cancer Causes & Control 2017; 28(4): 299 doi: 10.1007/s10552-017-0864-4
|
12 |
Lukasz Durko, Ewa Malecka-Panas. The Association Between Adiposity and Survival in Patients with Colorectal Cancer. Current Nutrition Reports 2016; 5(1): 48 doi: 10.1007/s13668-016-0157-7
|
13 |
Yeong Sook Yoon, NaNa Keum, Xuehong Zhang, Eunyoung Cho, Edward L. Giovannucci. Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis. Metabolism 2015; 64(10): 1324 doi: 10.1016/j.metabol.2015.06.013
|
14 |
Fernando Vidal-Vanaclocha, Olatz Crende, Cira García de Durango, Alejandro Herreros-Pomares, Sandra López-Doménech, Álvaro González, Eva Ruiz-Casares, Thierry Vilboux, Riccardo Caruso, Hipólito Durán, Antonio Gil, Benedetto Ielpo, Fernando Lapuente, Yolanda Quijano, Emilio Vicente, Leticia Vidal-Lartitegui, Eduardo M. Sotomayor. Liver prometastatic reaction: Stimulating factors and responsive cancer phenotypes. Seminars in Cancer Biology 2021; 71: 122 doi: 10.1016/j.semcancer.2020.08.001
|
15 |
Goran Miljuš, Vesna Malenković, Blagoje Đukanović, Nikola Kolundžić, Olgica Nedić. IGFBP-3/transferrin/transferrin receptor 1 complexes as principal mediators of IGFBP-3 delivery to colon cells in non-cancer and cancer tissues. Experimental and Molecular Pathology 2015; 98(3): 431 doi: 10.1016/j.yexmp.2015.03.035
|
16 |
Katarzyna Walkiewicz, Karolina Janion, Monika Gętek-Paszek, Ewa Nowakowska-Zajdel. The role of linoleic and α-linolenic acids and their metabolites in maintaining chronic inflammation and developing colorectal cancer. Postępy Higieny i Medycyny Doświadczalnej 2020; 74: 464 doi: 10.5604/01.3001.0014.4864
|
17 |
Aldona Kasprzak, Agnieszka Adamek. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer—From Basic Research to Potential Clinical Applications. International Journal of Molecular Sciences 2019; 20(19): 4915 doi: 10.3390/ijms20194915
|
18 |
Achim Bub, Anita Kriebel, Claudia Dörr, Susanne Bandt, Manuela Rist, Alexander Roth, Eva Hummel, Sabine Kulling, Ingrid Hoffmann, Bernhard Watzl. The Karlsruhe Metabolomics and Nutrition (KarMeN) Study: Protocol and Methods of a Cross-Sectional Study to Characterize the Metabolome of Healthy Men and Women. JMIR Research Protocols 2016; 5(3): e146 doi: 10.2196/resprot.5792
|
19 |
Shi-Yuan Liu, Wei Chen, Ehtesham Annait Chughtai, Zhe Qiao, Jian-Tao Jiang, Shao-Min Li, Wei Zhang, Jin Zhang. <i>PIK3CA</i> gene mutations in Northwest Chinese esophageal squamous cell carcinoma. World Journal of Gastroenterology 2017; 23(14): 2585-2591 doi: 10.3748/wjg.v23.i14.2585
|
20 |
Elena Shmakova, Irina Larionova, Tatiana Sudarskikh, Julia Kzhyshkowska. Macrophages - Molecular Pathways and Immunometabolic Processes. 2024; doi: 10.5772/intechopen.1007011
|
21 |
Wu Ning, Haijing Li, Fanqiang Meng, Jianhua Cheng, Xin Song, Guochao Zhang, Wenyue Wang, Shengming Wu, Junjian Fang, Kunpeng Ma, Jie Yang, Dongpo Pei, Fangting Dong. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography–mass spectrometry. Biomedical Chromatography 2017; 31(11) doi: 10.1002/bmc.3999
|
22 |
George Ciulei, Olga Hilda Orasan, Sorina Cezara Coste, Angela Cozma, Vasile Negrean, Lucia Maria Procopciuc. Vitamin D and the insulin‐like growth factor system: Implications for colorectal neoplasia. European Journal of Clinical Investigation 2020; 50(9) doi: 10.1111/eci.13265
|
23 |
J Olender, E Nowakowska-Zajdel, C Kruszniewska-Rajs, J Orchel, U Mazurek, A Wierzgoń, T Kokot, M Muc-Wierzgoń. Epigenetic silencing of endothelin-3 in colorectal cancer. International Journal of Immunopathology and Pharmacology 2016; 29(2): 333 doi: 10.1177/0394632015600371
|
24 |
Elizabeth M. Cespedes Feliciano, Candyce H. Kroenke, Jeffrey A. Meyerhardt, Carla M. Prado, Patrick T. Bradshaw, Andrew J. Dannenberg, Marilyn L. Kwan, Jingjie Xiao, Charles Quesenberry, Erin K. Weltzien, Adrienne L. Castillo, Bette J. Caan. Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer. Journal of Clinical Oncology 2016; 34(30): 3664 doi: 10.1200/JCO.2016.67.4473
|
25 |
Su Yon Jung, Wendy E. Barrington, Dorothy S. Lane, Chu Chen, Rowan Chlebowski, Giselle Corbie-Smith, Lifang Hou, Zuo-Feng Zhang, Min-So Paek, Carolyn J. Crandall. Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women. Menopause 2017; 24(3): 288 doi: 10.1097/GME.0000000000000753
|
26 |
Yin Long, Beatriz Sanchez‐Espiridion, Moubin Lin, Lindsey White, Lopa Mishra, Gottumakkala S. Raju, Scott Kopetz, Cathy Eng, Michelle A. T. Hildebrandt, David W. Chang, Yuanqing Ye, Dong Liang, Xifeng Wu. Global and targeted serum metabolic profiling of colorectal cancer progression. Cancer 2017; 123(20): 4066 doi: 10.1002/cncr.30829
|
27 |
Dariusz Waniczek, Marcin Nowak, Justyna Lorenc-Góra, Małgorzata Muc-Wierzgoń, Urszula Mazurek, Magda Bichalska-Lach, Zbigniew Lorenc. The transcriptional activity profile of inhibitor apoptosis protein encoding genes in colon cancer patients. Medicine 2021; 100(46): e27882 doi: 10.1097/MD.0000000000027882
|